Daver N, Basu S, Garcia-Manero G, Abbas HA, Konopleva M, Kadia TM DiNardo CD, Borthakur G, Alotaibi AS, Pemmaraju N, Jabbour E, Pierce SA, Brandt M, Takahashi K, Ning J, Kornblau SM, Sasaki K, Yilmaz M, Issa G, Short NJ, Matthews JA, Flores W, Andreeff M , Cortes JE, Ravandi F, Allison JP, Kantarjian HM, Sharma P
An around-the-horn PCR was performed on the pNZ8148 plasmid to obtain a backbone vector that was devoid of the Nisin promoter
The phase 2 dose-ranging trial (NCT02970942) included 320 individuals with histologically proven MASH and hepatic fibrosis F1-F3, randomizing them 3:3:3:1:1:1 to daily subcutaneous administration of semaglutide 0.1, 0.2, or 0.4 mg, or placebo for 72 weeks [18]
Apr 28th, 2026 How TB-500 Promotes Recovery and Angiogenesis TB-500 is a synthetic fragment of thymosin beta-4 associated with tissue repair and angiogenesis, but human evidence is limited, it is not FDA-approved, and its safety and effectiveness remain uncertain
However, further UAE research is needed to explore the full extent of PT-141s therapeutic benefits in this context
2003 doi: 10.1183/09031936.03.00000203a
